Article Details
Retrieved on: 2019-02-11 22:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Former Agios Pharmaceuticals CEO David Schenkein has joined the life science investing team at GV. Schenkein will co-lead the life science team at ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here